Clinical Research News
-
Clinical Research | News | 0 Comment | 08 Jul, 2019
Sangamo Therapeutics, a genomic medicine company, and Pfizer has announced updated results from the Phase 1/2 ...Read more
-
Takeda announces results from Phase IIIb/IV clinical trial for ADYNOVATE
Clinical Research | News | 0 Comment | 08 Jul, 2019
Takeda, an R&D-driven, global biopharmaceutical company with a leadership position in rare diseases has announced up...Read more
-
Sommetrics completes study of new sleep apnea treatment in ethnic Japanese subjects
Clinical Research | News | 0 Comment | 26 Jun, 2019
Sommetrics, a company dedicated to developing state of the art products to treat obstructive sleep apnea (OSA) has annou...Read more
-
FDA Grants Orphan Drug Designation to XWL-008 to treat Narcolepsy
Clinical Research | News | 0 Comment | 25 Jun, 2019
XW Laboratories Inc., a China headquartered clinical-stage biopharmaceutical company pioneering the discovery of novel s...Read more
-
Prestige Biopharma reports Ph III results for Tuznue
Clinical Research | News | 0 Comment | 24 Jun, 2019
Prestige BioPharma has announced positive top-line results from a Phase III global clinical trial (Troika) evaluati...Read more
-
Parexel launches an enhanced integrated outsourcing delivery model for FSP
Clinical Research | News | 0 Comment | 24 Jun, 2019
Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to marke...Read more
-
Asieris Completes Enrolment for US APL-1202 Phase Ib Clinical Trial
Clinical Research | News | 0 Comment | 24 Jun, 2019
Asieris, a China-based biotech company specializing in the development and commercialization of new drugs for the t...Read more
-
FasT CAR-19 Therapy Shows Positive Impact in Patients with (r/r) B-ALL
Clinical Research | News | 0 Comment | 21 Jun, 2019
Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage cellular immunotherapy company, on 21 June 2019, announc...Read more
-
Edesa Biotech receives approval to proceed with its clinical investigation
Clinical Research | News | 0 Comment | 20 Jun, 2019
Edesa Biotech, a clinical-stage biopharmaceutical company has reported that the U.S. Food and Drug Administration h...Read more
-
BI, Lilly announces results of new post-hoc analysis of data from the EMPA-REG OUTCOME trial
Clinical Research | News | 0 Comment | 17 Jun, 2019
Boehringer Ingelheim and Eli Lilly and Company have announced results of a new post-hoc analysis of data from the EMPA-R...Read more
-
Reistone Announces First Patient Dosed in Two Phase II Global Studies of SHR0302
Clinical Research | News | 0 Comment | 17 Jun, 2019
Reistone Biopharma Company Limited (Reistone), on 14 June 2019, announced dosing of the first patient in their Phase II ...Read more
-
Lumosa to Initiate Phase 2 Human Clinical Trial for LT3001 to treat Acute Ischemic Stroke
Clinical Research | News | 0 Comment | 14 Jun, 2019
Lumosa Therapeutics, on 13 June 2019, announced that the company is ready to commence the Phase 2 proof of concept (PoC)...Read more
-
China NMPA Approves Sinovant's Clinical Trial Application for Lefamulin
Clinical Research | News | 0 Comment | 14 Jun, 2019
Sinovant Sciences announced on 13 June 2019, that its Clinical Trial Application (CTA) for lefamulin has been accepted b...Read more
-
Terns Pharmaceuticals and Shanghai Tuosheng Biotechnology initiate TERN-101 first phase trial
Clinical Research | News | 0 Comment | 14 Jun, 2019
Terns Pharmaceuticals, Inc. and Shanghai Tuo Zhen Biological Technology Co., Ltd., on 13 June 2019, announced the launch...Read more
-
Dr. Reddy's announces positive results for psoriasis drug study
Clinical Research | News | 0 Comment | 11 Jun, 2019
Dr. Reddy’s has announced positive topline results from its Phase 2b study of PPC-06 (formerly referred to as...Read more
-
Ascentage Pharma presents new clinical data of apoptosis targeted drug candidates
Clinical Research | News | 0 Comment | 07 Jun, 2019
Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for can...Read more
-
CStone to initiate clinical development of CS1001 and BLU-554 in combination therapy for HCC
Clinical Research | News | 0 Comment | 06 Jun, 2019
CStone Pharmaceuticals has announced that it has received approval to initiate clinical development in C...Read more
-
Genentech announces meeting of primary endpoint of Ph III study
Clinical Research | News | 0 Comment | 04 Jun, 2019
Genentech, a member of the Roche Group has announced that the Phase III BLOCKSTONE study, conducted by Shionogi &am...Read more
